ODAIA Closes $15M Series C to Scale Pharma Commercial AI
ODAIA raised $15 million in Series C funding led by Monograph Capital, with Publicis Groupe's PHM joining as strategic investor and exclusive U.S. agency partner for its pharma commercial AI platform.
